TVARDI THERAPEUTICS, INC. — Income Charts
52 quarters of history · ending 2025-12-31 · SEC EDGAR
Revenue↑+20.3% +$434K
$3M
R&D
$5M
D&A
$24K
Operating Income↓-4.6% -$262K
$-6M
EBITDA
$24K
Interest Expense↓-15.4% -$4K
$22K
Pretax Income↑+93.9% +$16M
$-1M
Tax Provision
$0
Net Income↓-0.3% -$14K
$-6M
Operating Margin↑+1296.6pts
-92.9%
Net Margin↓-176.1pts
-372.9%